2020
DOI: 10.21037/jtd-2020-icc-007
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral and central mechanisms of cough hypersensitivity

Abstract: Overview of cough and cough hypersensitivity syndromeCough is an important physiological response to airway irritation but can become excessive and problematic in disease. The characteristic cough motor pattern is relatively simple, consisting of an initial inspiration, a brief expiration against a closed glottis and finally forced expiration with the glottis open (1,2). This motor pattern generates large airflow velocities that effectively clear the airways of irritant material. Accordingly, cough plays an es… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(24 citation statements)
references
References 132 publications
0
20
0
Order By: Relevance
“…The development of new potential treatments for RCC, including the first-in-class P2X3 and P2X2/3 receptor antagonist gefapixant [41,42,126,127], as well as more the recently developed eliapixant (BAY 1817080) [128], filapixant (BAY 1902607) [129], BLU-5937 [130], sivopixant (S-600918) [131,132] and agents acting on other pathways, has provided new insights into the pathophysiology of RCC including the role of P2X3 receptors in humans [13,[133][134][135]. The clinical effects of these agents are in contrast to data from animal studies [136]; this observation demonstrates the marked differences in receptor distribution and function between species.…”
Section: Treatments For Rcc Under Investigationmentioning
confidence: 99%
“…The development of new potential treatments for RCC, including the first-in-class P2X3 and P2X2/3 receptor antagonist gefapixant [41,42,126,127], as well as more the recently developed eliapixant (BAY 1817080) [128], filapixant (BAY 1902607) [129], BLU-5937 [130], sivopixant (S-600918) [131,132] and agents acting on other pathways, has provided new insights into the pathophysiology of RCC including the role of P2X3 receptors in humans [13,[133][134][135]. The clinical effects of these agents are in contrast to data from animal studies [136]; this observation demonstrates the marked differences in receptor distribution and function between species.…”
Section: Treatments For Rcc Under Investigationmentioning
confidence: 99%
“…At the same time it is responsible for limited efficacy of CC treatment. 11,12 The limited effectiveness of cause oriented treatment of CC encourages the application of other approaches including a search for treatable CC traits. Identifying different CC endotypes and biomarkers capable of predicting treatment response may facilitate a more specific therapeutic approach resulting in a higher success rate.…”
Section: Introductionmentioning
confidence: 99%
“…It is characterised by troublesome coughing in response to low level stimuli, loss of inhibitory cough control and abnormal laryngeal sensation. At the same time it is responsible for limited efficacy of chronic cough treatment [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…51 , 133 , 142 -Asthma, -COPD. 38 Table 2. Role in neurogenic inflammation, polymorphism, and cough suppression…”
Section: Chemosensitivitymentioning
confidence: 99%
“… 37 Central descending pathways of the prefrontal cortical region are involved with urge-to-cough and the initiation of a voluntary cough or its suppression; this occurs in the presence or absence of a peripheral activation stimulus. 38 For example, chronic cough patients were less able to suppress cough in response to capsaicin inhalation, when compared to healthy controls, reportedly due to failure of inhibitory descending pathways. 39 In accordance, patients with chronic cough challenged with sufficient inhaled capsaicin to induce urge-to-cough demonstrated lower activation of cough inhibitory descending pathways by functional magnetic resonance imaging, compared to healthy subjects.…”
Section: Applied Anatomy and Physiology Of Cough Stretch And Chemoreceptorsmentioning
confidence: 99%